Introduction
First, let me congratulate Dr. Victor Moroz on the occasion of the the 70 th anniversary of the Institute for General Reanimatology of the Russian Academy of Medical Sciences. It is a truly amazing accomplishment and one that I know would have had special meaning to the late Dr. Peter Safar. There is a rich and special history of interaction between the late Drs. Peter Safar and Dr. Vladimir Negovsky, two giants in the history of resuscitation. To commemo rate your anniversary celebration, I have provided this review article, which presents a very brief histor ical overview of the interface between Drs. Safar and Negovsky, followed by a description of the evolution of the International Resuscitation Research Center (IRRC) at the University of Pittsburgh School of Medicine into the Safar Center for Resuscitation Research including an overview of some of our cur rent programs along with a selection of interesting recent findings from our center.
The Safar Negovsky Legacy
On September 5 th 1962, Drs. Peter Safar chaired a panel discussion at the First European Anesthesiology Congress in Vienna, Austria on the topic of «Controversial aspects of resuscitation». Despite the challenges imposed by the cold war in the early 1960s, Dr. Safar invited Dr. Vladimir Negovsky to participate [1] having read one of the English trans lated versions of Dr. Negovsky's work. That meeting began a lifelong friendship and mutual admiration between the two individuals who arguably became the most important figures in the history of modern resus citation. Dr. Safar was impressed by four seminal aspects of the pioneering work of Dr. Negovsky [2] [3] [4] , namely 1) his establishing a resuscitation research cen ter as early as 1937, 2) his early documentation of the use of centripetal intra arterial blood pumping and mechanical ventilation to resuscitate that was initially suggested by Russian physician Andreev in 1913, 3) his coining of the term «reanimatology» and 4) his description of the concept of «post resuscitation dis ease». Dr. Safar's own pioneering work in resuscitation (reviewed in 5) included the development of mouth to mouth resuscitation, the assembly and dissemina tion of CPR, his work on the application of mild hypothermia in cerebral resuscitation, his key role in the development of emergency medicine services for field resuscitation (which also included design of the modern cabin configuration of the ambulance), semi nal studies on the pathomechanisms of human death in natural and man made disasters, and ultimately, his spearheading the development of novel approaches to resuscitation such as emergency preservation and resuscitation (EPR). I believe that the mutual respect and sharing of ideas between these two colleagues influenced Negovsky to become more treatment ori ented and Safar to further study pathophysiologic mechanisms [1] (Figure 1 ). The passing of these two giants and great leaders in resuscitation -both during the first week in August 2003 -represented a huge loss for the resuscitation community. However, their work has provided us with an incredibly rich founda tion upon which new approaches can be developed to «save hearts and brains too good to die».
Transition from the IRRC to the Safar Center
In 1994, Dr. Peter Safar stepped down as direc tor of the IRRC, to focus his efforts more on his research and a number of other projects. At that time, Dr. Safar had established research programs at the IRRC in the areas of cardiopulmonary arrest, hemor rhagic shock, and disaster medicine. I had the good fortune of being named director after a local competi tion between three faculty investigators in the Department of Anesthesiology and Critical Care Medicine at the University of Pittsburgh. Over the past 12 years, several new programs have been devel oped at the center and the landscape of several of the existing programs has evolved. Currently, we have programs in traumatic brain injury (TBI), cardiopul monary arrest, hemorrhagic shock, and ultra advanced resuscitation approaches such as EPR. Several important new investigators have been added to the center, and a number of key collaborators are involved. New and/or enhanced roles for molecular biology, free radical biology, proteomics, CNS injury models, and rehabilitation research have emerged. Our center has a multidisciplinary faculty which spans the departments of Critical Care Medicine, Neurological Surgery, Pediatrics, Surgery, Physical Medicine and Rehabilitation, Emergency Medicine, Anesthesiology, and Pathology. A synthesis of some of the most exciting and important findings within each of these programs is provided below. Finally, one for mer program is currently inactive, and that is the pro gram in disaster medicine.
Current Investigation at the Safar Center for Resuscitation Research Traumatic Brain Injury: Bench to bedside
This represents a new area of research that has developed during the past 10 years. It has been the most productive area of investigation in our center and includes work as principal investigator by eight faculty investigators, and numerous important col laborators and trainees. Currents studies in our cen ter are focused on mechanisms in the evolution of sec ondary damage including delayed neuronal death, oxidative and nitrative stress, dopamine systems, poly ADP ribose polymerase (PARP), kinase and phosphatase mediated events, serotonin pathways, and endogenous neuroprotectants such as adenosine. We and our collaborators have taken advantage of a number of important new tools in this work on TBI, including the use of a contemporary model of experi mental TBI controlled cortical impact (CCI), the application of novel magnetic resonance imaging (MRI) tools such as perfusion imaging and non inva sive assessment of macrophage accumulation in injured brain, novel proteomic and oxidative lipidomic approaches, and in vivo electrochemical monitoring techniques like fast scan cyclic voltam metry, among others methods. We have used the CCI model of TBI in both rats in mice for over sixty stud ies in experimental TBI. This model was developed for use in rats by Dr. C. Edward Dixon, one of the Safar Center faculty [6] , and is both highly repro ducible, and well characterized. In addition, we have developed several modifications of this model, most notably the use of combined TBI plus secondary hypoxemia [7] which models the important combina tion of these insults that is often observed clinically after TBI [8] . Finally, our group has led the way in linking bench bedside in the study of cellular and molecular mechanism of secondary damage and repair in human TBI. We have accomplished this using two important resources, assessing biochemical and molecular markers in cerebrospinal fluid (CSF) drained through ventriculostomy catheters in the treatment of intracranial hypertension in patients (both adults and children) with severe TBI [reviewed in 9], and by performing western analysis and immunohistochemistry of brain tissue resected emergently from critically ill patients with severe TBI in the treatment of refractory intracranial hyper tension and impending herniation [10] [11] [12] .
Mechanism of neuronal death
This area of investigation has been the focus of Safar Center investigator, Dr. Robert Clark who has contributed a number of important reports in both experimental and clinical TBI. Dr. Clark's most sig nificant contributions in this area have included the first documentation of caspase 3 and caspase 1 activa tion in human head injury [10] (Figure 2) , and early descriptions of the role of both caspase activation and apoptosis initiating factor (AIF) release in experi mental TBI [13, 14] . Most recently Dr. Clark and his group have published two reports in human TBI that have substantially advanced our knowledge in this area. First, Zhang et al [12] reported that the impor tant cell survival pathway linked to protein kinase B Р е д а к ц и о н н ы е с т а т ь и (PKB, also know as Akt) is activated in human TBI. PKB when activated is phorphorylated and inhibits the intrinsic (mitochondrial) pathway of apoptosis. This is believed to be accomplished by PKB mediated phosphorylation and inactivation of downstream death signals such as BAD and by phosphorylation and activation of the pro survival signal cyclic AMP response element binding protein (CREB). Using brain tissue samples from 15 patients with severe TBI, Dr. Clark's group convincingly demonstrated that PKB and its downstream signals are phosphorylated and thus activated in human head injury supporting a role for this important pathway and suggesting that it may be a target for therapeutic manipulation. These findings have taken on even greater significance given the recent work from the laboratory of Dr. Gary Steinberg suggesting that mild therapeutic hypother mia may confer some of its benefit through the enhancement of this pathway [15] .
A second important recent publication from Dr. Clark's laboratory by Satchell et al [16] , reported that levels of the key cellular apoptosis trigger cytochrome C are increased in CSF of infants and children with severe TBI particularly in victims of inflicted childhood neurotrauma (i. e., child abuse or «shaken baby syndrome»). Because release of cytochrome c has been shown to be a pivotal trigger of the apoptotic cascade in a number of experimental systems, this study of 67 infants and children sug gests that delayed neuronal death plays an important role in pediatric TBI, and that this pathway may be a particularly important therapeutic target in victims of child abuse. Targeting delayed neuronal death appears to represent an important therapeutic target for the development of new therapies for TBI, partic ularly in infants and young children.
Oxidative and nitrative stress Dr. Hulya Bayir of the Safar Center, in collabo ration with Dr. Valerian Kagan, at the University of Pittsburgh Center for Free Radical and Antioxidant Health, have carried out a series of studies over the past 5 years that has contributed significantly to our understanding of the role of oxidative and nitrative stress in experimental and clinical TBI [17] [18] [19] [20] [21] [22] [23] [24] . Using a comprehensive battery of markers of oxida tive stress, Bayir et al [16] reported marked increases in lipid peroxidation and depletion of endogenous antioxidants such as ascorbate and total antioxidant reserve in CSF samples in children with severe TBI. Striking and concerning was the extent and progres sive nature of the ascorbate depletion in these patients over the initial 5 days after severe TBI ( Figure 3 ). This report strongly suggests that one of the mechanisms underlying the well recognized heightened vulnerability of patients with severe TBI to secondary brain insults in the intensive care unit, reported by Gopinath et al [25] , is loss of antioxidant defenses. More recently, in preliminary studies, Dr.
Bayir -in collaboration with Dr. David Adelson and his recent randomized controlled clinical trial of the use of mild to moderate hypothermia in infants with severe TBI, demonstrated that cooling significantly attenuated the loss of antioxidants after TBI [22] suggesting that this mechanism accompanies the reduction in intracranial pressure that is known to be produced with the use of mild and moderate hypothermia in clinical TBI. Finally, in recent studies in our laboratory, Dr. Bayir has demonstrated, using neuronal nitric oxide synthase knockout mice, that the nitric oxide pathway in neurons and likely specif ically in mitochondria contribute importantly to the nitration and inactivation of the important mito chondrial antioxidant enzyme Manganese superoxide dismutase (MnSOD) [23, 24] . She similarly reported that MnSOD nitration and inactivation occur in con tusion samples from humans with severe TBI [23] . This is another example of the type of bench to bed side work that we feel is important to enhancing our understanding of cellular and molecular mechanism of secondary injury in severe TBI. Additional research on the role of oxidative and nitrative stress in TBI is warranted.
Proteomics applications
One of the best methods currently available to try to unravel the mechanism of secondary injury and repair in the injured brain after TBI or cardiac arrest is the use of proteomics. Using both 2 D gel and high throughput multiblot approaches allows the simulta neous investigation of many proteins, along with the examination of critical protein post translational modification such as phosphorylation (Figure 4 ). Dr.
Larry Jenkins and his associates in our center have contributed the initial appli cation of this contemporary technology to the field of experimental TBI [26] , the first use of this method in a developmen tal TBI model [27] , and early use in clin ical TBI [28] . In a manuscript in press [27] , Dr. Jenkins' group used a 2D differ ence gel electrophoresis (DIGE) method to study the response to experimental brain injury in the rat hippocampus at 14 days after CCI injury in developing (17 day old) rats. Changes in a large number of important proteins across numerous functional categories such as energy metabolism and mitochondrial function, synaptic function, oxidative stress, and cell stress and chaperone proteins were identified. For example, 30% decreases in pyruvate dehydrogenase E1 beta and alpha subunits were noted, while the glial stress protein GFAP was increased over 300 fold. More recently, Gao et al [28] used a 2D gel approach to study CSF from infants and children with Р е д а к ц и о н н ы е с т а т ь и either inflicted (child abuse) or non inflicted (acci dental) TBI. He demonstrated unique increases in the acute phase reactants such as haptoglobin iso forms in infants with accidental but not inflicted TBI. This suggests that factors such as a delay in pre sentation or chronic or repeated injury may blunt the traditional acute phase response in victims of TBI from child abuse.
Adenosine Our group, in collaboration with Dr. Edwin Jackson of the University of Pittsburgh Center for Clinical Pharmacology, has carried out a number of studies demonstrating marked increased in levels of adenosine in brain interstitial fluid and CSF after both experimental and clinical TBI [29] [30] [31] [32] . We have also characterized some of the putative effects of adenosine production in the injured brain, in both our model systems and in humans [31, [33] [34] [35] [36] . Adenosine is believed to play a critical endogenous neuroprotectant role through effects at multiple receptors including A1, A2a, A2b, and A3. For exam ple, adenosine, formed during the breakdown of ATP in ischemic brain regions has important anti excito toxic and anti convulsant effects in brain in some model systems, while, effects of adenosine at A2a and A2b receptors can, among other effects, increase cere bral blood flow (CBF) [37, 38] . One can readily envisage that reduced metabolic demands and improved CBF represent valuable endogenous pro tectant effects early after brain injury from either trauma or ischemia.
We recently published two studies that provide insight into the potential neuroprotective role for adenosine in TBI. First, we reported that early after CCI, adenosine A1 receptor knockout mice develop lethal status epilepticus [36] . Status epilepticus has not been noted by us or others in numerous stud ies with the mouse CCI model. Nevertheless, it occurs in the A1 recep tor knockout mouse even when moder ate injury levels are used, and is seen independent of gender. This finding sup ports a powerful anti convulsant effect of adenosine mediated by effects at the A1 receptor after experimental TBI, and may provided important clues toward the development of highly targeted anti excitotoxic therapies. We have also recently reported that non selective and A2a selective adenosine agonists confer powerful CBF promoting effects in both the normal brain and early after CCI in rats [35] (Figure 5 ). It is well recognized that early after experimental and clinical TBI, CBF is reduced [39, 40] . This has suggested posttraumatic hypoperfusion or ischemia as a putative therapeutic target. Using novel perfusion MRI via the continuous arterial spin labeling method, we demonstrated that CBF could be normalized early after injury by local injection of non selective adenosine agonists [35] . Thus, optimal manipulation of the adenosine cascade may represent an avenue for the early post resuscitation phase in human head injury and is an area of active investiga tion at our center.
Serotonin 1A receptor agonists Another area of investigation targeting phar macological manipulation of injured brain after severe TBI is via the serotonin transmitter system. Recent work by Dr. Anthony Kline in our center [41] [42] [43] has demonstrated beneficial effects of sero tonin 1A receptor agonists against both neuronal cell death and functional impairments in rats after CCI. Agents such as either repinotan or 8 hydroxy DPAT administered after the injury were shown to be effective [41] [42] [43] . Although the mechanism or mechanisms underlying the beneficial effects of serotonin 1A receptor agonists in TBI remain to be determined, it may be more than coincidence that these agents share important anti excitotoxic prop erties with adenosine and adenosine A1 receptor agonists, including the ability to hyperpolarize neu rons, decrease glutamate release via actions at pre synaptic glutamatergic terminals, and inhibit sodi um channels. This suggests that excitotoxic pathways are of special importance early after TBI. Finally, the possibility of synergism of serotonin and adenosine targeting therapies in experimental or clinical TBI has not been investigated but might represent an intriguing opportunity.
MRI applications in experimental TBI
MRI is a powerful tool for the investigation of experimental TBI and cardiac arrest. We have collab orated extensively with Dr. Chien Ho and his research group at the Pittsburgh NMR center for bio medical research at Carnegie Mellon University. We have used novel perfusion MRI by the continuous arterial spin labeling method to measure CBF in rat brain. This non invasive method, which uses arterial water as the label, is highly advantages in that it can generate serial maps of CBF -allowing for temporal and regional assessment. In a series of studies, we have assessed CO 2 reactivity after CCI [44] , early posttraumatic hypoperfusion [39] , the effects of anes thesia on CBF [45] , serial assessment of CBF and blood brain barrier permeability [46] , study of CBF at long outcome times as late as one year after injury [47] , and the aforementioned studies of the effect of adenosine receptor agonists [33, 35] . This year, we expanded the application of this non invasive method of CBF assessment to the studies in mice [48] . Successful adaptation of this method to the study of mice allows for the investigation of a wealth of transgenic and knockout animals, and we believe, will provide considerable insight into the contribu tion of posttraumatic ischemia to the evolution of secondary damage after TBI.
Inflicted childhood neurotrauma
An important problem in the field of pediatric TBI is inflicted childhood neurotrauma (child abuse, shaken baby syndrome). By assessing CSF from infants and children with severe TBI, it has become clear that victims of inflicted childhood neurotrauma often exhibit a unique biochemical profile versus vic tims of accidental injures (motor vehicle accidents, falls, etc). As previously discussed, victims of inflict ed childhood neurotrauma may exhibit a number of unique biochemical and molecular features such as 1) a failure to mount some aspects of the acute phase response to injury such as an increase in haptoglobin levels [28] , 2) accentuated delayed neuronal death as reflected by a late rise in cytochrome c levels [16] and neuron specific enolase (NSE) levels [49] in CSF, and 3) exaggerated stress response as reflected by high CSF levels of heat shock proteins such as HSP 70 [50] , among others. These findings may reflect chron ic injury, delay in presentation, a propensity toward apoptosis related to the young age of these victims (they are almost always infants), and/or to the fre quent occurrence of hypoxemic episodes in these patients from untreated seizures or apnea [51] . Our findings suggest that treatment of inflicted childhood neurotrauma in infants may benefit from therapies effective in hypoxic ischemic encephalopathy (such as mild hypothermia) and possibly therapies target ing apoptosis which may be responsible for delayed neuronal death.
We have also measured biomarkers of brain injury (such as NSE) in serum in addition to CSF in an attempt to identify victims of mild or moderate inflicted TBI in an attempt to prevent misdiagnosis which is an important problem for general pediatricians or emer gency medicine physicians. In a recent report, Dr. Rachel Berger, working on this area at our center and Children's Hospital of Pittsburgh measured serum NSE in 98 infants who presented with non specific symptoms that are often consistent with those seen in missed cases of inflicted childhood neurotrauma (such as vomiting without diarrhea or irritability) [52] . There was an increase in serum NSE in 79% of the children diagnosed with inflicted childhood neurotrauma and in 80% of the children who, in retrospect, may have been additional missed cases. The use of serum biomarkers, such as NSE, may represent an important new diagnostic adjunct for use in this setting [reviewed in 53] .
The link between research in acute TBI and rehabilitation
Our center has traditionally focused on the acute and sub acute phases after CNS injury those most ger mane to resuscitation. However, faculty in our center in the Departments of both Neurological Surgery and Physical Medicine and Rehabilitation have been focused recently, in part, on more delayed phases after TBI. This was suggested as an important area for future research by Professor Vladimir Negovsky in his «Essays on Reanimatology» in 1980 [4] . Dixon et al [54] reported on sustained cognitive deficits in rats over a one year follow up period after TBI produced by CCI. More recently Drs. Amy Wagner and Anthony Kline have been studying the effect of environmental enrichment on long term cognitive outcome in rats after CCI. Environmental enrichment represents an interesting strategy that models the use of rehabilita tion in the clinical setting. Environmental enrichment has powerful beneficial effects on outcome. Wagner et al [55] reported that the beneficial effect of environ mental enrichment on cognitive outcome was observed only in males after CCI in rats implying important gen der differences. Subsequent studies suggest that the environmental enrichment effects on dopamine sys tems and neurotrophin production after experimental TBI are also, in part, gender specific [56, 57] . These studies represent on aspect of a novel approach to studying therapies in experimental TBI, namely, assess ment of therapies relevant to rehabilitation in the sub acute or chronic phases after injury. Both drugs and cel lular therapies (such as stem cells) may have important potential in helping the brain re wire after injury.
Cardiopulmonary arrest Optimization of therapeutic hypothermia after cardiopulmonary arrest
A major focuses of investigation in cardiopul monary arrest at the Safar Center is in optimizing the Р е д а к ц и о н н ы е с т а т ь и use of therapeutic hypothermia. Dr. Safar and a num ber of other investigators used of therapeutic hypothermia in the late 1950s and early 1960s. Indeed, therapeutic hypothermia was incorporated into the «ABCs» of resuscitation in the early 1960s ( Figure 6 ) [58] . However, in that era, moderate (28-32°C) rather than mild (23-35°C) hypothermia was used and often for too long of a duration leading to infec tions and other complications. Along with the classic paper of Busto et al [59] , Dr. Peter Safar's work in clin ically realistic experimental cardiac arrest launched the re assessment of mild cooling which has led to pos itive clinical trials in both adults [60, 61] , and new borns [62] . It is noteworthy that Dr. Fritz Sterz and his investigative team at Vienna General Hospital in Austria an alumnus of our center led the successful European study of mild hypothermia after cardiac arrest. These findings have led the American Heart Association and the International Liaison committee on resuscitation (ILCOR) to recommend mild cooling for comatose survivors of cardiopul monary arrest. For more information on the use of mild hypothermia in CNS insults, we would suggest several reviews and editorials [63] [64] [65] .
Recently, we have carried out two studies focused on defining the optimal application of mild hypothermia. We test ed the efficacy of the application of mild hypothermia during CPR rather than after restoration of spontaneous circula tion which is the approach that was effec tive in the aforementioned clinical trials in both adults and infants. We used a sce nario that included ventricular fibrillation (VF) followed by 3 min of no flow, 7 min of basic life support (BLS) and 10 addi tional min of VF with simulated unsuc cessful advanced cardiac life support (ACLS). We then randomized dogs to 20 min of either continued ACLS at nor mothermia, or moderate hypothermia induced via venovenous extracorporeal shunt cooling. Therapeutic hypothermia induced during the arrest produced a dra matic beneficial effect namely, normal outcomes. In contrast, dogs maintained normothermic developed multiple organ failure and remained comatose [66] . More recently, we reported that delaying the application of hypothermia from 10 min to 20 min in the resuscitation greatly reduced its effectiveness suggesting a critical time window for the optimal intra arrest appli cation of cooling [67] . Coupled with the published reports on success of post arrest cooling [60, 61] and the recent work of Bernard et al [68] , our findings suggests that to optimize outcomes after cardiac arrest, cooling during resuscitation should be promptly initiated prob ably with a cold intravenous bolus and continued for 12-24 hours after resuscitation.
Asphyxial arrest novel mechanistic insight and treatment
Related to the strong link of several of our cen ter investigators to pediatric critical care medicine and pediatric neurointensive care, there is consider able research in the area of pediatric resuscitation. Dr. Ericka Fink, working in the laboratory of Robert Clark has developed a new rat model of asphyxial car diopulmonary arrest mimicking the pediatric condi tion [69] . In that model, anesthetized rats 17 days of age are subjected to an asphyxial insult that rapidly leads to full cardiopulmonary arrest. A total insult duration of 8.5 min is used, and results -after resus citation using chest compressions, epinephrine, and sodium bicarbonate administration in survival with neuronal death in selectively vulnerable brain regions ( Figure 7) . This model has now been used in a series of studies to evaluate hypothermia [70] along with a number of novel therapies targeting both oxidative stress and poly ADP ribose polymerase activation [71, 72] . This is an area of high activity at our center and the model is an excellent one which shows great promise both for studying mechanisms and screening novel therapies.
Hemorrhagic shock Work in the area of hemorrhagic shock in our center is under the direction of Dr. Samuel Tisherman, a trauma surgeon with critical care exper tise, and is focused on novel approaches to prolong the «golden hour». The use of mild hypothermia in this regard has been evaluated in a series of studies in rats and it has been shown to powerfully delay and/or prevent acute death [73] [74] [75] [76] [77] . These studies have also suggested a systemic effect of hypothermia rather than a local effect on gut alone, since isolated cooling of the gut was not effective [76] . Similarly, the bene fit of mild cooling does not appear to result from a reduction in cytokines [77] . One recent study from Dr. Tisherman's group is particularly noteworthy. Using a clinically relevant, pig model with trauma and intensive care, Wu et al [78] tested the hypothe sis that mild hypothermia, induced with intravenous cold saline (ice cold or room temperature) would improve survival after hemorrhagic shock in pigs. Using a model of venous blood withdrawal over 3 hours and spleen transection, three groups were com pared: 1) normothermia (38°C), induced with warmed saline; 2) mild hypothermia (34°C) induced with intravenous infusion of iced saline; and 3) mild hypothermia (34°C), induced with room temperature saline. After the shock phase, shed blood was returned and intensive care was continued to 24 hours. Remarkably, the hypothermia group in which cooling was achieved with room temperature saline exhibited the highest survival rate. Use of iced saline administration in shock, reduced the fluid required to achieve target blood pressure, but may appears to have maintained blood pressure at the expense of vasoconstriction and increased serum lactate levels. Thus, mild hypothermia during hemorrhagic shock, induced by infusion of room temperature saline, improves survival in a clinically relevant model of hemorrhagic shock and trauma. However, the use of iced saline in this model had detrimental effects. These findings suggest that optimal methods for induction of hypothermia must be addressed for each potential indication, e. g. cardiac arrest versus TBI versus hemorrhagic shock.
Emergency preservation and resuscitation (EPR)
Exsanguination cardiac arrest has an extremely poor prognosis [79] , likely related at least in part to the limited effectiveness of conventional resuscita tion methods (i. e., CPR, BLS and ACLS) in this set ting. This form of arrest is common among combat casualties and can also be seen in some cases of civil ian trauma. As previously discussed, some of Dr. Negovsky's pioneering work focused on the problem of exsanguination cardiac arrest and used an intra arterial injection of oxygenated blood plus epineph rine targeting the resuscitation of exsanguinated wounded soldiers (reviewed in 3). During the last 15 years of his life, Dr. Safar worked to develop a novel approach to this otherwise refractory form of arrest. He initially termed this approach «Suspended ani mation for delayed resuscitation» [80] . The approach was developed in a dog model of exsan guination cardiac arrest and used a rapid aortic flush of ice cold saline (with jugular venous drainage) to promptly (within 15-20 minutes) achieve a state of profound hypothermic preservation (Figure 8 ). Successful emergency preservation for periods of between 1 and 3 hours would allow transport of the casualty to the far forward treatment facility in the military setting or trauma bay in the civilian setting where surgical repair could take place followed by delayed resuscitation using cardiopulmonary bypass. In a series of reports, we were able to achieve initial ly between 30 min and 1 hour of preservation and eventually -2 hours of preservation with favorable Р е д а к ц и о н н ы е с т а т ь и outcome [81] [82] [83] . Some of our most recent studies suggest that 3 hours of EPR induced during exsan guination cardiac arrest may be achievable [84] .
A recent publication on this topic by our center is noteworthy. Wu et al [85] tested whether or not this approach could be successful if exsanguination cardiac arrest was preceded by about 2 hours of hem orrhagic shock. In that study, good neurological out come was achieved after a 1 hour period of hypother mic preservation even if it was preceded by 2 hours of hemorrhagic shock. Favorable outcome could only be achieved if the period of preservation was followed with 36 hours of mild hypothermia followed by slow re warming. Dr. Drabek in our group has also recent ly developed a rat model of EPR to both carry out molecular studies of the mechanisms of hypothermic preservation and to screen novel therapies [86] .
This novel approach to resuscitation has been named EPR in Dr. Safar's honor and may represent the new CPR for cases of refractory arrest particular ly those due to exsanguination. Finally, recent studies by Behringer in Vienna have begun to apply this approach to cases of refractory normovolemic cardiac arrest [87] and have built on Dr. Safar's suggestions of an even broader potential application of EPR. A multi center clinical feasibility trial of EPR in the setting of civilian trauma resulting in exsanguination cardiac arrest is in the planning stages, and an initial consortium meeting of interested trauma centers was held by Dr. Tisherman in 2005 in Pittsburgh.
Conclusions and future directions
Building on the remarkable foundation laid by Dr. Peter Safar, and capitalizing on many of the important clues in the seminal work of Dr. Vladimir Negovsky, the Safar Center for Resuscitation Research continues to better under stand the pathobiology of clinical conditions that require resuscitation, and ultimately improve therapies. Over the past 12 years, the scope of the work at the Safar Center has expanded to include programs in the areas of TBI and rehabilitation, and the importance of pediatric CNS injury and resuscitation have also increased in scope. Future investiga tion at the Safar Center, I believe, will include additional work on mecha nisms in the evolution of secondary damage after TBI, cardiac arrest, and hemorrhagic shock, and development and translation of novel therapies for these conditions. New tools such as proteomics, lipidomics, genomics and advanced MRI applications are important to our ability to better understand the cybernetic post resus citation disease, first introduced by Dr. Negovsky, which follows these severe insults. We are also beginning to put substantial effort into studying blast injury and the combination of TBI and hem orrhagic shock. These conditions are important, albeit very unfortunate, consequences of terrorist attacks with improvised explosive devices in both the military and civilian sectors [88, 89] . We are currently investigating novel resuscitation fluids and therapies in experimental models of these important conditions. We are also placing increased emphasis on the importance of rehabili tation, and the need for research in that area. Finally, we hope to pursue additional work in ultra advanced resuscitation techniques, includ ing EPR, and look forward to the challenge of an initial clinical trial in exsanguination cardiopul monary arrest. Acknowledgement This article is written in honor of the late Drs. Peter Safar and Vladimir Negovsky. Dr. Kochanek is supported by the National Institutes of Health, USA, National Institute of Neurological Disorders and Stroke (NS 30318, NS 38087), the National Institute of Child Health and Human Development (T32 HD40686) the United States Army (W81XWH 06 1 0247), the Centers for Disease Control and Prevention, USA (University of Pittsburgh Center for Injury Research and Control). We also thank the Laerdal Foundation for Acute Medicine for the support of many of trainees who carried out the studies pre sented in this review. 
